• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.

作者信息

Di Lorenzo Giuseppe

出版信息

Eur Urol. 2008 Feb;53(2):332. doi: 10.1016/j.eururo.2007.03.074.

DOI:10.1016/j.eururo.2007.03.074
PMID:17445974
Abstract
摘要

相似文献

1
Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.关于“多西他赛和雌莫司汀治疗雄激素非依赖性前列腺癌患者的预后和预测因素：单机构经验”的社论评论
Eur Urol. 2008 Feb;53(2):332. doi: 10.1016/j.eururo.2007.03.074.
2
Editorial comment on: prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.关于《多西他赛和雌莫司汀治疗雄激素非依赖性前列腺癌患者的预后和预测因素：单机构经验》的编辑评论
Eur Urol. 2008 Feb;53(2):331. doi: 10.1016/j.eururo.2007.03.073.
3
Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience.多西他赛和雌莫司汀治疗雄激素非依赖性前列腺癌患者的预后和预测因素：单机构经验
Eur Urol. 2008 Feb;53(2):323-31. doi: 10.1016/j.eururo.2007.03.072. Epub 2007 Apr 5.
4
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.雄激素剥夺疗法联合多西他赛和雌莫司汀与单独雄激素剥夺疗法治疗高危局限性前列腺癌（GETUG 12）：一项 3 期随机对照临床试验。
Lancet Oncol. 2015 Jul;16(7):787-94. doi: 10.1016/S1470-2045(15)00011-X. Epub 2015 May 28.
5
Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts.多西他赛联合或不联合磷酸雌莫司汀与米托蒽醌在雄激素依赖性和非依赖性人前列腺癌异种移植模型中的活性比较
J Urol. 2003 May;169(5):1729-34. doi: 10.1097/01.ju.0000062500.75703.2c.
6
Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.雌莫司汀、多西他赛和沙利度胺联合用药治疗雄激素非依赖性前列腺癌的临床前及临床评估
BJU Int. 2007 May;99(5):1047-55. doi: 10.1111/j.1464-410X.2007.06763.x.
7
Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.新辅助化学激素治疗包括完全雄激素阻断，随后在根治性前列腺切除术前给予多西他赛和磷酸雌莫司汀治疗日本高危局限性前列腺癌患者的短期临床病理结局。
World J Surg Oncol. 2012 Jan 4;10:1. doi: 10.1186/1477-7819-10-1.
8
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.多西他赛与雌莫司汀治疗晚期激素难治性前列腺癌的II期研究中预后因素及疗效的特征分析
Onkologie. 2005 Nov;28(11):573-8. doi: 10.1159/000088297.
9
Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.多中心随机II期研究：多西他赛、雌莫司汀和泼尼松两种给药方案对比米托蒽醌加泼尼松用于转移性激素难治性前列腺癌患者的疗效
J Clin Oncol. 2005 May 20;23(15):3343-51. doi: 10.1200/JCO.2005.12.187. Epub 2005 Feb 28.
10
Are prostate-specific antigen changes valid surrogates for survival in hormone-refractory prostate cancer? A meta-analysis is needed!
J Clin Oncol. 2007 Dec 10;25(35):5673-4; author reply 5674. doi: 10.1200/JCO.2007.14.5268.